CMS Moves to Foster Access to Generics, Biosimilars in New Rule
- The Trump administration put out a proposed rule on Wednesday that aims to foster access to generics and biosimilars through a push for price transparency around pharmaceutical drugs administered under Medicare Part D. In the second part of its advance notice for calendar year 2021 for Medicare Advantage and Medicare Part D, the Centers for...
